z-logo
open-access-imgOpen Access
Identification of a Neonate with Thalassemia Intermedia Despite Premarital Screening Program in Mazandaran Province (Co-inheritance of Hb Knossos and IVS II-1 G> A Mutations)
Author(s) -
Hossein Karami,
Hossein Jalali,
Mehrad Mahdavi,
Mohammad Reza Mahdavi
Publication year - 2017
Publication title -
research in molecular medicine
Language(s) - English
Resource type - Journals
eISSN - 2322-133X
pISSN - 2322-1348
DOI - 10.29252/rmm.5.2.34
Subject(s) - inheritance (genetic algorithm) , intermedia , thalassemia , identification (biology) , medicine , traditional medicine , genetics , pediatrics , biology , gene , history , botany , performance art , art history
Corresponding Author: Mohammad Reza Mahdavi Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Phone: +98-1133292929 E-mail: Mahdavi899@gmail.com Abstract Background: Beta thalassemia is a common health problem in Iran especially in Northern provinces. Premarital screening for thalassemia is compulsory in Iran and identification of the carriers is based on primary CBC (Cell Blood Count) and hemoglobin electrophoresis. Silent mutations on β-globin gene have borderline or normal hematological indices that cannot be detected in premarital screening. Materials and methods: A four years old boy affected with β-thalassemia was referred to the lab for molecular analysis. During the screening program for βthalassemia, his father and mother were diagnosed as αand β-thalassemia carrier respectively. Results: The results of molecular analysis showed that in addition to the α-globin single gene deletion (α), the father had also carried a silent mutation on his βglobin gene named HBB c.82G>T or Hb Knossos that was missed in screening program. Conclusion: The presented case shows that using CBC and hemoglobin electrophoresis in premarital screening program for detecting β-thalassemia carriers is not a valid approach and individuals who are carriers of silent β-globin gene mutations are missed in this procedure. Hence, in premarital screening program precise molecular investigation especially when the partner is a typical βthalassemia carrier is recommended.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom